FT Reports: NHS launches “subscription” scheme for antibiotics with pharma sector
The Financial Times reports today that the NHS is launching a subscription scheme for antitbiotics, with the pharma industry. The scheme is… Read More
The Financial Times reports today that the NHS is launching a subscription scheme for antitbiotics, with the pharma industry. The scheme is… Read More
Commissioned by Lord Sainsbury and authored by Professor James Moore and Yunus Kutlu, Imperial College has published a report on innovation adoption in the UK… Read More
Giovanna’s annual talk to the Imperial Business School took place last week; here we share the presentation Deck. Had she known in 2002 what she… Read More
We are delighted to share the Informa list of 30 Rising Leaders in Life Sciences, which features Forte Medical’s very own CEO Giovanna Forte. Read More
The partnership between Forte Medical and Owen Mumford USA was launched today at the OCTANe Medical Innovation Technology Forum (MTIF) at Newport Beach, CA 28-29 October 2019. … Read More
It is very interesting to read that pharma companies are to be incentivised to develop new antibiotics to combat antimicrobial resistance (AMR). A significant yet… Read More
Today’s Hippocratic Post features an overview on the importance of urine and the evidence supporting why our technology plays such a vital role in… Read More
New evidence showing a 70% reduction in false positive dipped specimens Extended uptake by the NHS Investment including a JV to create a Smart Peezy… Read More
We are delighted to announce the appointment of consultant midwife and lifelong campaigner for positive childbirth, Sheena Byrom OBE to our Advisory Panel. Sheena Byrom… Read More
Giovanna Forte, CEO was delighted to be one of 10 British executives to make their way to UC Irvine (UCI) for the Greater Irvine Chamber’s… Read More